Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02214095Phase 1Terminated
Phase 1, randomised, double-blind trial of glucosamine sulphate in chronic periodontitis, sponsored by Ain Shams University. Primary endpoint: Interleukin-1 beta at 3 months. Started Jan 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02214095.